ArticleAmerican journal of preventive cardiology2025
Absolute impact of lipid levels on coronary heart disease in a real-world primary prevention cohort of 730,236 people.
Article in American journal of preventive cardiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Associations of preconception retinal microvasculature with lipid profiles from mid-pregnancy to three months postpartum.NPJ cardiovascular health · 2026Article
- The risk of cardiovascular events in the Italian adult population without prior history of CVD: a systematic review of follow-up studies.Frontiers in cardiovascular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and aims: The impact of the association of LDL-c levels with coronary heart disease is unambiguous in people with previous cardiovascular disease. In primary prevention, however, it has been poorly studied. We analyzed the impact of the association of lipid levels with coronary heart disease in a population with no previous cardiovascular disease. We included potential variations by sex and age. Methods: Retrospective cohort analysis of records from the SIDIAP Catalan database, Spain. We selected ≥35-year-olds without previous cardiovascular disease or lipid-lowering medications. The LDL, HDL, and triglycerides levels were the exposure and coronary heart disease was the outcome. Cox regression and Lin additive models estimated the relative and absolute associations, respectively. Results: We analyzed the records from 730,236 participants; follow-up: 6.7 years; mean (SD) age: 58.5 (13.9) years, and 42.2 % of them were men. The overall CHD incidence rate was 3.47 (3.42-3.52) events per 1000 person-years; it was higher in men than in women, with 4.98 (4.88-5.07) and 2.39 (2.33-2.45) events per 1000 person-years, respectively. One mmol/L increase in LDL-c, HDL-c, and TGs showed HRs (95 %CI) of 1.26 (1.24-1.29), 0.60 (0.57-0.63), and 1.16 (1.13-1.19), respectively. The absolute differences for LDL-c and TGs were less than one additional CHD event per 1000 person-years; and two fewer events for HDL-c. Conclusions: The moderate to low increment in the incidence of CHD by 1 mmol/L of lipid increase represented low numbers of additional events in this low-risk Mediterranean population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.